Valued at USD 67.79 million in 2024, the U.S. hemostasis valve market is anticipated to expand at a CAGR of 5.6% between 2025 and 2034, with product segmentation playing a critical role in shaping competitive positioning and growth potential. The market is primarily segmented by product type into fixed hemostasis valves, sliding hemostasis valves, and rotating hemostasis valves, each catering...